Portal de investigación
- Inicio
- Proyectos y Estudios
- ESTUDIO DE FASE 2, DOBLE CIEGO, MULTICENTRICO Y ALEATORIZADO DE COMPARACION ENTRE TENOFOVIR DISOPROXIL FUMARATO, EMTRICITABINA MAS TENOFOVIR DISOPROXIL FUMARATO Y ENTECAVIR EN EL TRATAMIENTO DE PACIENTES QUE PRESENTEN HEPATITIS B CRONICA CON ENFERMEDAD HE PATICA DESCOMPENSADA Y EN LA PREVENCION DE LA RECIDIVA DE LA HEPATITIS B TRAS UN TRANSPLANTE.
ESTUDIO DE FASE 2, DOBLE CIEGO, MULTICENTRICO Y ALEATORIZADO DE COMPARACION ENTRE TENOFOVIR DISOPROXIL FUMARATO, EMTRICITABINA MAS TENOFOVIR DISOPROXIL FUMARATO Y ENTECAVIR EN EL TRATAMIENTO DE PACIENTES QUE PRESENTEN HEPATITIS B CRONICA CON ENFERMEDAD HE PATICA DESCOMPENSADA Y EN LA PREVENCION DE LA RECIDIVA DE LA HEPATITIS B TRAS UN TRANSPLANTE.
Datos básicos
- Código:
- GS-US-174-0108
- Protocolo:
- GS-US-174-0108
- EUDRACT:
- 2005-004096-37
- NCT:
- Centro:
- Dotación:
- Año de incio:
- Año de finalización:
Documentos
- No hay documentos
Participantes
Financiadores - Promotores
Resultados del Ensayo Clínico
Brain abscesses in early post-liver transplantation.
Minguez Sabater, Alejandro; (...); Prieto Castillo, Martin
Article. 10.1016/j.eimce.2021.09.007. 2021
Everolimus plus minimized tacrolimus on kidney function in liver transplantation: REDUCE, a prospective, randomized controlled study.
Gómez-Bravo M; (...); Santoyo J
Article. 10.17235/reed.2022.8549/2021. 2022
Good posttransplant outcome using donors after cardiac death (DCD) when applying strict selection criteria
de la Varga, MF; (...); Castillo, MP
Meeting Abstract. 2021
Good post-transplant outcomes using liver donors after circulatory death when applying strict selection criteria: A propensity-score matched-cohort study.
Fernandez-de la Varga, Margarita; (...); Aguilera, Victoria
Article. 10.1016/j.aohep.2022.100724. 2022
Long term follow-up in HCV infected patients with end stage chronic kidney disease after DAA therapy
Martinez-Camprecios, J; (...); Buti, M
Meeting Abstract. 2021
Long-Term Effectiveness, Safety, and Patient- Reported Outcomes of Self-Administered Subcutaneous Hepatitis B Immunoglobulin in Liver Post-Transplant Hepatitis B Prophylaxis: A Prospective Non-Interventional Study
Roche B; (...); Samuel D
Article. 10.12659/AOT.936162. 2022
Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy
Martinez-Camprecios, Joan; (...); Buti, Maria
Article. 10.1016/j.gastrohep.2022.12.004. 2023
Metabolic syndrome before liver transplantation: does it have an impact on post liver transplantation outcomes?
Herreras Lopez, Julia; (...); Aguilera, Victoria
Article. 10.17235/reed.2022.8384/2021. 2022
mTOR inhibitors a potential predisposing factor for chronic hepatitis E: Results from the prospective collaborative CHES study (Chronic Hepatitis EScreening in patients with immune impairment and increased transaminases levels).
Riveiro-Barciela, Mar; (...); Esteban, Rafael
Article. 10.1016/j.gastrohep.2023.01.010. 2023
OVERCOMING BARRIERS TO CARE FOR DELTA INFECTED PATIENTS
Carvalho-Gomes, Angela; (...); Berenguer, Marina
Meeting Abstract. 2022
Overcoming barriers to care for Delta infected patients
Bono, Ariadna; (...); Berenguer, Marina
Meeting Abstract. 2023
SIMILAR POST-TRANSPLANT OUTCOMES USING DONORS AFTER CARDIAC DEATH WHEN APPLYING STRICT SELECTION CRITERIA
de la Varga, MF; (...); Aguilera, V
Meeting Abstract. 2021
Survey to evaluate the implementation of the recommendations on the comprehensive diagnosis of viral hepatitis in a single extraction: where are we?
Cabezas, Joaquin; (...); Crespo, Javier
Meeting Abstract. 2023
SURVEY TO EVALUATE THE IMPLEMENTATION OF THE RECOMMENDATIONS ON THE COMPREHENSIVE DIAGNOSIS OF VIRAL HEPATITIS IN A SINGLE EXTRACTION: WHERE ARE WE?
Cabezas, Joaquin; (...); Crespo Garcia, Javier
Meeting Abstract. 2023
The role of HBIG in real life for patients undergoing liver transplantation due to HDV-related cirrhosis
Rodriguez-Tajes, Sergio; (...); Forns, Xavier
Article. 10.1111/liv.15777. 2024